Fonte: Biochemical Pharmacology. Unidade: FCF
Assuntos: HIV, ANTIRRETROVIRAIS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIGÓN, Lorena et al. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, v. 192, p. 1-34 art. 114666, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114666. Acesso em: 19 nov. 2024.APA
Vigón, L., Román, P. M., Mora, S. R., Torres, M., Puertas, M. C., Mateos, E., et al. (2021). Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, 192, 1-34 art. 114666. doi:10.1016/j.bcp.2021.114666NLM
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666Vancouver
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666
